Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration-Reference-Cited by-同舟云学术

Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration

Published:2013-09 Issue:9 Volume:120 Page:1893-1900
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Jackson Timothy L.,Chakravarthy Usha,Kaiser Peter K.,Slakter Jason S.,Jan Ernest,Bandello Francesco,O'Shaughnessy Denis,Gertner Michael E.,Danielson Linda,Moshfeghi Darius M.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference36 articles.

1. Age-related macular degeneration;Jager;N Engl J Med,2008

2. Age related macular degeneration;Chakravarthy;BMJ,2010

3. Age-related macular degeneration;Coleman;Lancet,2008

4. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy;Rodel;Int J Radiat Biol,2007

5. Irradiation dose-response effects on angiogenesis and involvement of nitric oxide;Hadjimichael;Anticancer Res,2005

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial;The Lancet;2024-07

2. Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-03-06

3. Gamma radiation coupled ADP-ribosyl transferase activity of Pseudomonas aeruginosa PE24 moiety;Applied Microbiology and Biotechnology;2023-02-18

4. Other;Radiation Therapy of Benign Diseases;2023

5. Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options;International Journal of Molecular Sciences;2022-02-26